BEYONDSPRING INC.

BYSI
Delayed Quote. Delayed  - 01/15 04:00:00 pm
12.88USD -0.54%

Turn to zoom
Prev.12.9500
Open12.8500
High13.2600
Low12.5400
Volume328 300
Latest news
4d ago
12/29
12/29
12/29
Chart BEYONDSPRING INC.
Technical analysis trends
Short TermMid-TermLong Term
TrendBullishNeutralNeutral
Resistance13,617,318,0
Spread/Res.-4,9%-26%-28%
Spread/Supp.9,1%29%24%
Support11,89,9910,4
Financials
Sales 2020 - - -
Net income 2020 -59,4 M - -
Net Debt 2020 - - -
P/E ratio 2020 -6,87x
Yield 2020 -
Capitalization 504 M 504 M -
Capi. / Sales 2020 -
Capi. / Sales 2021 43,2x
Nbr of Employees 61
Free-Float 28,5%
Company
BeyondSpring Inc. is a global clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of immuno-oncology cancer therapies. The Company’s lead product Plinabulin, is being studied in late-stage clinical trials as an anti-cancer agent in combination...

>> Read more
Sector :
Bio Therapeutic Drugs
Calendar :
2021-01-14 Presentation
Trading Rating :
Investor Rating : -

Income Statement Evolution
Consensus
Mean consensus BUY
Number of Analysts 5
Average target price 33,25 $
Last Close Price 12,88 $
Spread / Highest target 234%
Spread / Average Target 158%
Spread / Lowest Target 94,1%